ClinicalTrials.gg
Sign In

Gastroenteritis clinical trials

The registry lists 237 studies for Gastroenteritis across more than 10 countries. 16 are recruiting or about to start. 134 of them are mainly about Gastroenteritis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03. Counting its 25 narrower conditions too, such as Crohn Disease: 6,063 studies, 1,308 open.

Get an email when these change. Save the Gastroenteritis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
170
Status unknown
21
Terminated
16
Recruiting
13
Withdrawn
8
Active, not recruiting
5

Phase

Phase 3
63
Phase 2
34
Phase 1
23
Phase 4
23
Early Phase 1
1

Where

United States
58
Canada
24
France
14
India
12
Netherlands
11
Italy
10

Who runs them

GlaxoSmithKline (25) · Merck Sharp & Dohme LLC (10) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · The Hospital for Sick Children (6) · NIZO Food Research (6) · Bausch Health Americas, Inc. (4) · HilleVax (4) · Ellodi Pharmaceuticals, LP (4)

What is being tested here

Drugs under test in Gastroenteritis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ondansetron159
Rifaximin101
Cyclophosphamide101
Thymoglobulin101
Methylprednisolone101
Vedolizumab101
RIX4414 vaccine038
RotaTeq025
HIL-214024
Cendakimab033

Drug classes tested here Antiemetics 1 open · Corticosteroids 1 open

Coming up

2phase 3 studies under way
7studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 13 Gastroenteritis studies recruiting now, 5 (38%) set no upper age limit and 8 (62%) stop at 75 or younger. 11 (85%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (23%) take healthy volunteers.

Recruiting studies that take each age, of 13
AgeWomenMen
106 (46%)6 (46%)
187 (54%)7 (54%)
305 (38%)5 (38%)
405 (38%)5 (38%)
505 (38%)5 (38%)
655 (38%)5 (38%)
755 (38%)5 (38%)
855 (38%)5 (38%)

Across all 237 studies, recruiting or not: 80% stop at 75 or younger and 78% at 65; 77% take children; 0% are for women only and 3% for men only; 41% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gastroenteritis studies take

Of 25 phase 3 interventional studies under Gastroenteritis, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 319 mo11–36 · 25 studies18 mo10–34 · 21 studies—
Interventional, no phase11 mo4–22 · 17 studies——
Observational43 mo30–161 · 17 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 237. Browse all 237 → or search them.